Guest Editors
Dr. Walid Shalata
Email: walid.shalata@gmail.com
Affiliation: The Legacy Heritage Cancer Center and Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
Homepage:
Research Interests: Neoplasms, Lung Cancer, Immunotherapy, Chemotherapy
Summary
Immunotherapy and chemotherapy are two of the most widely used and fundamental treatment modalities in oncology. Immunotherapy leverages the body's immune system to recognize and attack cancer cells, while chemotherapy uses cytotoxic drugs to target rapidly dividing cells, including cancer cells. This special issue delves into the intersection of these two approaches, exploring both their complementary and contrasting roles in the dynamic field of cancer treatment. It offers a comprehensive review of the current state of these therapies, focusing on their underlying mechanisms, potential for synergy, and the promise of more personalized and effective treatment strategies. While challenges such as toxicity and resistance continue to hinder progress, the articles, reviews, and case studies presented in this issue provide valuable insights into how the integration of immunotherapy and chemotherapy can shape the future of cancer treatment. Together, these therapies bring renewed hope for improving patient outcomes through more tailored and innovative approaches.
Keywords
Cancer Immunotherapy, Chemotherapy Resistance, Combination Therapies, Synergistic Treatment Strategies, Personalized Cancer Treatment, Tumor Microenvironment
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue